The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
BMC Cardiovasc Disord. 2024 Feb 26;24(1):124. doi: 10.1186/s12872-024-03799-x.
This study aims to compare the clinical effects of two distinct surgical approaches, namely 3D printing-assisted extracorporeal pre-fenestration and Castor integrated branch stent techniques, in treating patients with Stanford type B aortic dissections (TBAD) characterized by inadequate proximal landing zones.
A retrospective analysis was conducted on 84 patients with type B aortic dissection (TBAD) who underwent thoracic endovascular aortic repair (TEVAR) with left subclavian artery (LSA) reconstruction at our center from January 2022 to July 2023. Based on the different surgical approaches, the patients were divided into two groups: the group assisted by 3D printing for extracorporeal pre-fenestration (n = 44) and the group using the castor integrated branch stent (n = 40). Clinical indicators: including general patient information, operative time, surgical success rate, intraoperative and postoperative complication rates, re-intervention rate, and mortality, as well as postoperative aortic remodeling, were compared between the two groups. The endpoint of this study is the post-TEVAR mortality rate in patients.
The surgical success rate and device deployment success rate were 100% in both groups, with no statistically significant difference (P > 0.05). However, the group assisted by 3D printing for extracorporeal pre-fenestration had a significantly longer operative time (184.20 ± 54.857 min) compared to the group using the castor integrated branch stent (152.75 ± 33.068 min), with a statistically significant difference (t = 3.215, p = 0.002, P < 0.05). Moreover, the incidence of postoperative cerebral infarction and beak sign was significantly lower in the group assisted by 3D printing for extracorporeal pre-fenestration compared to the castor-integrated branch stent group, demonstrating statistical significance. There were no significant differences between the two groups in terms of other postoperative complication rates and aortic remodeling (P > 0.05). Notably, computed tomography angiography images revealed the expansion of the vascular true lumen and the reduction of the false lumen at three specified levels of the thoracic aorta. The follow-up duration did not show any statistically significant difference between the two groups (10.59 ± 4.52 vs. 9.08 ± 4.35 months, t = 1.561, p = 0.122 > 0.05). Throughout the follow-up period, neither group experienced new endoleaks, spinal cord injuries, nor limb ischemia. In the castor-integrated branch stent group, one patient developed a new distal dissection, prompting further follow-up. Additionally, there was one case of mortality due to COVID-19 in each group. There were no statistically significant differences between the two groups in terms of re-intervention rate and survival rate (P > 0.05).
Both 3D printing-assisted extracorporeal pre-fenestration TEVAR and castor-integrated branch stent techniques demonstrate good safety and efficacy in treating Stanford type B aortic dissection with inadequate proximal anchoring. The 3D printing-assisted extracorporeal pre-fenestration TEVAR technique has a lower incidence of postoperative cerebral infarction and beak sign, while the castor-integrated branch stent technique has advantages in operative time.
本研究旨在比较两种不同手术方法,即 3D 打印辅助体外预开窗和 Castor 一体化分支支架技术,在治疗 Stanford 型 B 型主动脉夹层(TBAD)患者中的临床效果,这些患者近端锚定区不足。
回顾性分析了 2022 年 1 月至 2023 年 7 月在我中心接受胸主动脉腔内修复术(TEVAR)并重建左锁骨下动脉(LSA)的 84 例 B 型主动脉夹层(TBAD)患者。根据不同的手术方法,将患者分为两组:3D 打印辅助体外预开窗组(n=44)和 Castor 一体化分支支架组(n=40)。比较两组患者的一般患者信息、手术时间、手术成功率、术中及术后并发症发生率、再次干预率和死亡率,以及术后主动脉重塑情况。本研究的终点是患者 TEVAR 术后死亡率。
两组手术成功率和器械放置成功率均为 100%,差异无统计学意义(P>0.05)。然而,3D 打印辅助体外预开窗组的手术时间(184.20±54.857 min)明显长于 Castor 一体化分支支架组(152.75±33.068 min),差异有统计学意义(t=3.215,p=0.002,P<0.05)。此外,3D 打印辅助体外预开窗组术后脑梗死和喙状征的发生率明显低于 Castor 一体化分支支架组,差异有统计学意义。两组其他术后并发症发生率和主动脉重塑差异无统计学意义(P>0.05)。值得注意的是,CT 血管造影图像显示胸主动脉三个特定水平的血管真腔扩张和假腔缩小。两组的随访时间无统计学差异(10.59±4.52 与 9.08±4.35 个月,t=1.561,p=0.122>0.05)。在整个随访期间,两组均未出现新的内漏、脊髓损伤或肢体缺血。Castor 一体化分支支架组中有 1 例患者出现新发远端夹层,需要进一步随访。此外,两组各有 1 例因 COVID-19 死亡。两组的再干预率和生存率差异无统计学意义(P>0.05)。
3D 打印辅助体外预开窗 TEVAR 和 Castor 一体化分支支架技术在治疗 Stanford 型 B 型主动脉夹层近端锚定区不足方面均具有良好的安全性和疗效。3D 打印辅助体外预开窗 TEVAR 技术术后脑梗死和喙状征发生率较低,而 Castor 一体化分支支架技术手术时间具有优势。